86. Pulmonary arterial hypertension
1,083 clinical trials,   667 drugs   (DrugBank: 122 drugs),   98 drug target genes,   185 drug target pathways

Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02304198
(ClinicalTrials.gov)
April 201426/11/2014Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAHA Single-arm, Open-label, Extension Study to Evaluate the Long-term Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)Pulmonary Arterial HypertensionDrug: UdenafilDong-A ST Co., Ltd.NULLCompleted18 YearsN/ABoth59Phase 2;Phase 3Korea, Republic of
2NCT01553721
(ClinicalTrials.gov)
August 20111/1/2012Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)Pulmonary Arterial HypertensionDrug: udenafil;Drug: placeboDong-A ST Co., Ltd.NULLCompleted18 YearsN/ABoth63Phase 2Korea, Republic of